Anti-obesity Pharmacotherapy and Inflammation
Anti-obesity Pharmacotherapy and Inflammation
Active, not recruiting · NCT05756764 · Registry updated 2025-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-obesity Pharmacotherapy and Inflammation | Body Weight, Dyslipidemias, Inflammation, Insulin Resistance, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not stated | 2025-09-09 | NCT05756764 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO | New Orleans | United States | 1 |
| Ochsner Health System - Biospecimen | New Orleans | United States | 1 |